Outlook Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

Outlook Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,869	Closed	-$545K	–	213
2021 Q1	$545K	Buy	5,869 +587	+11%	+$60.1K	0.19%	136
2020 Q4	$473K	Buy	5,282 +108	+2%	+$9.91K	0.17%	134
2020 Q3	$535K	Sell	5,174 -2,640	-34%	-$285K	0.21%	107
2020 Q2	$618K	Buy	7,814 +326	+4%	+$24.3K	0.26%	82
2020 Q1	$433K	Buy	7,488 +276	+4%	+$15.9K	0.24%	86
2019 Q4	$389K	Buy	7,212 +1,473	+26%	+$79.9K	0.22%	101
2019 Q3	$300K	Buy	5,739 +244	+4%	+$11.4K	0.18%	132
2019 Q2	$265K	Buy	5,495 +468	+9%	+$22.4K	0.17%	134
2019 Q1	$254K	Buy	5,027 +4,007	+393%	+$236K	0.21%	126
2018 Q4	$605K	Buy	+1,020	New	+$65.8K	0.28%	89

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Outlook Wealth Advisors's EBS Position: Q2 2021 in Review

Outlook Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 5,869 shares — an estimated $545K sold.

Outlook Wealth Advisors first reported a position in EBS in Q4 2018 and held it in 10 quarters. The position peaked at $618K in Q2 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Outlook Wealth Advisors reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Outlook Wealth Advisors sold 5,869 Emergent Biosolutions shares in Q2 2021, an estimated $545K.
Outlook Wealth Advisors first reported a position in Emergent Biosolutions in Q4 2018 and held it in 10 quarters.
Outlook Wealth Advisors's Emergent Biosolutions position peaked at $618K in Q2 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Outlook Wealth Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.